Search Results 61-70 of 13036 for CDP-Choline
(1)(1)C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes. Radiographics. 2016 Jan-Feb; 36 (1):279-92. View PubMed; Crush AB ...
In 2012, Mayo Clinic received approval from the Food and Drug Administration to produce and administer Choline C-11 injections, which is an imaging agent ...
This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also ...
The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...
"It's a 30-minute exam. Based on our calculations, our C-11 choline can see cancer in the body seven years before any other form of imaging." Because the dye's ...
Conte GM, Moassefi M, Decker PA, Kosel ML, McCarthy CB, Sagen JA, Nikanpour Y, Fereidan-Esfahani M, Ruff MW, Guido FS, Pump HK, Burns TC, Jenkins RB, ...
Biomarkers from circulating cell-free tumor DNA in peripheral blood will identify patients with metastatic prostate cancer diagnosed with C11 choline PET/CT ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.